Ulcerative Colitis Treatment Options: How to Understand Your Choices

Key takeaways
- Several treatment options exist. These include aminosalicylates, corticosteroids, biologics, targeted oral medications, and surgery in certain circumstances.
- The best ulcerative colitis treatment depends on your situation. Disease severity, past treatment responses, safety considerations, and preferences all influence the choice.
- Treatment is not always a straight line. Patients sharing their experiences with mama health frequently described using different medications over time, including corticosteroids and biologics.
- Switching medications can be part of UC management. Some people need a different treatment because their current medication is not effective enough, stops working, or causes side effects.
- Long-term remission matters. Maintenance treatment is an important part of managing ulcerative colitis, even when symptoms improve.
If you've recently been diagnosed with ulcerative colitis (UC), understanding your treatment options can feel overwhelming. You may hear unfamiliar medication names, wonder whether you'll need steroids or biologics, or worry about what happens if your first treatment doesn't work.
The good news is that there are several established ulcerative colitis treatment options, and care can be adapted to your needs.
Ulcerative colitis is a chronic inflammatory bowel disease (IBD) that causes inflammation and ulcers in the lining of the colon and rectum. Treatment aims to reduce inflammation, achieve remission, and help people maintain it over time. [1]
But there is no single best treatment for everyone.
Your gastroenterologist considers factors such as disease severity, previous medications, potential side effects, and your personal preferences when discussing treatment choices.
Insights from people living with ulcerative colitis, shared through mama health, highlight how different treatment journeys can be and why understanding your choices matters.
What are the main treatment options for ulcerative colitis?
The main ulcerative colitis treatment options include anti-inflammatory medications, corticosteroids, biologic therapies, targeted oral medications, immunomodulators, and surgery.
Different treatments work in different ways. Some are used to bring active inflammation under control, while others help maintain remission.
The American College of Gastroenterology (ACG) and American Gastroenterological Association (AGA) provide evidence-based recommendations for these approaches. [1, 2]
Aminosalicylates (5-ASAs): Often used for mild to moderate UC
Aminosalicylates reduce inflammation in the lining of the intestine. They are commonly used for mild to moderate ulcerative colitis.
Examples include:
- Mesalamine (also called mesalazine)
- Sulfasalazine
- Balsalazide
Mesalamine is available in several forms, including oral tablets or capsules, suppositories, and enemas.
The location of inflammation helps determine which formulation a doctor may recommend. For example, rectal medications can be especially useful when inflammation is limited to the rectum.
Aminosalicylates may be used both to achieve remission and to maintain it. Their effectiveness depends on the extent and severity of the disease. [1]
Corticosteroids: Short-term treatment for active inflammation
Corticosteroids can reduce inflammation during an ulcerative colitis flare.
Examples include:
- Prednisone
- Prednisolone
- Budesonide MMX
- Intravenous corticosteroids, used in hospital settings for severe disease
These medications are generally intended for short-term use rather than long-term maintenance.
Prolonged systemic corticosteroid use can cause side effects such as sleep disturbances, mood changes, increased infection risk, bone loss, and changes in blood sugar.
For this reason, clinical guidelines recommend against using corticosteroids to maintain ulcerative colitis remission. [1]
What patients told mama health: Corticosteroids were a recurring topic in patient experiences.
Some patients described concerns about side effects and uncertainty about whether symptoms would return while reducing steroid treatment.
These experiences highlight an important question to discuss with your gastroenterologist: What is the longer-term plan after steroid treatment?
Biologic therapies: Targeting specific inflammatory pathways
Biologic medications target particular components of the immune system involved in inflammation.
They are important ulcerative colitis treatment options for people with moderate to severe disease.
Examples include:
- TNF inhibitors: Infliximab, adalimumab, and golimumab
- Integrin inhibitors: Vedolizumab
- Interleukin inhibitors: Ustekinumab, mirikizumab, risankizumab, and guselkumab
Depending on the medication and formulation, biologics may be administered through intravenous infusions or injections.
Some are given at an infusion center, while certain injection formulations can be administered at home following appropriate training.
Before starting biologic treatment, doctors typically assess relevant infection risks and vaccination status.
The AGA recommends several biologic and other advanced therapies for adults with moderate to severe UC. The choice depends partly on previous treatment exposure, the expected benefits, individual risks, and patient preferences. [2]
What patients told mama health: Biologic therapies featured prominently in conversations about treatment experiences.
Patients described considering or moving to advanced treatments when earlier medications did not provide sufficient relief or stopped being effective.
For someone considering biologics for the first time, these experiences may offer reassurance that advanced treatment is an established part of ulcerative colitis care.
Targeted oral medications: Additional options for moderate to severe UC
Targeted oral therapies act on specific immune pathways involved in ulcerative colitis.
Two important groups are:
JAK inhibitors
Examples include tofacitinib and upadacitinib.
These medications block Janus kinase signaling pathways involved in inflammation.
They are taken orally, but require consideration of potential risks, including serious infections, blood clots, cardiovascular events, and other safety concerns in certain patient groups.
In the United States, FDA labeling restricts the use of some JAK inhibitors based on previous treatment history.
S1P receptor modulators
Examples include ozanimod and etrasimod.
These medications influence the movement of certain immune cells through the body. They are also taken orally.
Doctors consider relevant heart, liver, eye, infection, and medication-interaction risks before selecting these therapies. [1, 2]
Oral treatment may appeal to people who prefer not to receive infusions or injections. However, convenience alone does not determine which medication is appropriate.
Immunomodulators: Medications used in selected situations
Immunomodulators affect immune system activity and may be used in certain ulcerative colitis treatment plans.
Examples include azathioprine and mercaptopurine, which belong to a group called thiopurines.
Thiopurines are not recommended as the only medication for bringing moderate to severe active UC into remission. However, they may have a role in maintaining remission in selected patients or in combination with certain biologics.
They require laboratory testing and attention to potential side effects, including infections and other long-term risks. [2]
Surgery: An option when medicines are insufficient or complications develop
Surgery may be considered when ulcerative colitis remains uncontrolled despite medical treatment, when serious complications occur, or when certain precancerous or cancerous changes develop.
The main surgical approach involves removing the colon and rectum, known as a proctocolectomy.
Depending on the situation, reconstructive options may include an ileal pouch-anal anastomosis (J-pouch) or a permanent ileostomy.
Removing the colon and rectum eliminates the diseased tissue affected by UC, although surgery can have lasting effects on bowel function and may require ongoing care.
Surgery is not necessarily the final step for every patient. It can also be an appropriate treatment option based on individual circumstances. [3]
What is the best ulcerative colitis treatment?
The best ulcerative colitis treatment is the one that offers an appropriate balance of effectiveness, safety, and practicality for your individual condition.
There is no universal medication that works best for everyone.
A gastroenterologist may consider several factors:
- Disease severity: Mild inflammation may require different therapy from moderate or severe disease.
- Location of inflammation: Disease limited to the rectum may respond to different formulations than extensive colitis.
- Previous treatments: Past responses, loss of effectiveness, or side effects influence future choices.
- Safety and medical history: Existing health conditions, infection risks, and pregnancy plans can affect medication selection.
- Daily-life preferences: Tablets, injections, and infusions may fit differently into work, family, and travel routines.
- Insurance and cost: Coverage requirements and out-of-pocket expenses may affect access to medications.
The AGA's guideline for moderate to severe ulcerative colitis also challenges the idea that every patient must exhaust older medications before receiving advanced therapy.
For some people with moderate to severe disease, earlier use of advanced treatment may be more appropriate than a prolonged step-by-step escalation. [2]
This means the treatment journey is not necessarily the same for two people with the same diagnosis.
Why do people with ulcerative colitis sometimes need to switch treatments?
People with ulcerative colitis may need to change treatments because a medication does not achieve remission, becomes less effective, causes unacceptable side effects, or no longer fits their circumstances.
This does not mean they have done anything wrong.
In mama health's patient experience research, treatment challenges emerged as a recurring theme.
Patients described several situations:
- Mesalamine did not sufficiently control their symptoms.
- Steroids helped initially, but symptoms returned during dose reduction.
- A biologic worked for a period before losing effectiveness.
- Side effects made an otherwise effective medication difficult to continue.
- Access or insurance problems disrupted a prescribed treatment plan.
These accounts show how different individual responses can be.
One patient may experience sustained remission with an early treatment, while another may need to explore several medications with their gastroenterologist.
Clinical guidelines also recognize that previous treatment exposure influences which advanced therapies may be appropriate next. [2]
The key takeaway: Needing to switch treatments is not a personal failure. It is one of the situations that gastroenterologists consider when adapting ulcerative colitis care.
What can real patients teach us about ulcerative colitis treatment?
Experiences shared through mama health show that ulcerative colitis treatment often involves balancing symptom control, medication side effects, practical concerns, and uncertainty about the future.
Several important themes emerged from patients' experiences.
Finding an effective treatment may take time
Some patients described trying different medications before finding an option that helped them reach remission.
The path was not always predictable. A treatment that worked well for one person did not necessarily produce the same results for another.
Side effects can influence treatment choices
Patients reported that steroid side effects, concerns about infusions, and difficulties with oral or injected medications affected daily life.
For some, managing side effects became an important part of conversations about whether to continue or change a medication.
Understanding treatment decisions matters
Patients often relied on their gastroenterologist's recommendations when choosing between treatment options.
However, some also described uncertainty about why a particular medication had been selected or how it worked.
These experiences highlight the value of shared decision-making.
You can ask your gastroenterologist: Why this medication, and why now?
Access to treatment can be challenging
Patients also described difficulties involving medication costs, insurance approvals, and delays in receiving prescribed treatments.
These practical concerns can add stress to an already demanding experience.
Discussing insurance requirements and available financial support with a care team may help patients prepare for potential access challenges.
These themes are drawn from patient experiences shared with mama health. Individual accounts illustrate different perspectives and should not be interpreted as evidence that a treatment will work similarly for everyone.
How do you know whether ulcerative colitis treatment is working?
Gastroenterologists assess treatment response using a combination of symptoms, laboratory tests, and examinations of intestinal inflammation.
Feeling better is important, but symptoms alone do not always show whether inflammation has resolved.
Doctors may assess:
- Rectal bleeding: Whether bleeding has decreased or stopped.
- Bowel movements: Changes in frequency, urgency, and stool consistency.
- Fecal calprotectin: A stool marker that can help assess intestinal inflammation.
- C-reactive protein (CRP): A blood marker of inflammation.
- Colonoscopy or flexible sigmoidoscopy: Procedures that allow doctors to assess the intestinal lining.
Current guidelines emphasize achieving lasting remission without corticosteroids and improving inflammation seen during endoscopy. [1]
The time needed to assess effectiveness differs by medication. Some therapies work relatively quickly, while others may require weeks or longer.
Some patients sharing their experiences with mama health described trying several therapies before finding one that worked for them.
Their experiences highlight why discussing treatment expectations early can be useful.
One question patients may consider asking is:
How long should we expect this medication to take effect, and how will we assess whether it is working?
What happens after ulcerative colitis goes into remission?
After ulcerative colitis enters remission, maintenance treatment aims to keep inflammation controlled and reduce the likelihood of relapse.
Remission means that symptoms have improved or disappeared. Doctors may also assess whether inflammation has healed inside the colon.
Maintenance treatment depends on the type and severity of UC and the medication used to achieve remission.
Some people continue aminosalicylates, while others remain on biologic or targeted therapies.
Corticosteroids are not recommended for maintaining remission because of their long-term risks. [1]
One recurring theme in mama health's patient accounts was the importance patients placed on continuing maintenance medication, even after feeling better.
Feeling better may be a sign that treatment is working, rather than a sign that it is no longer needed.
Stopping or changing medication without discussing it with a gastroenterologist may increase the risk of losing disease control.
Can diet and lifestyle changes help with ulcerative colitis management?
Diet and lifestyle adjustments can help people address symptoms, maintain nutrition, and support their overall well-being, but they do not replace medical treatment for intestinal inflammation.
There is no single diet proven to cure ulcerative colitis or consistently prevent flares in adults with inflammatory bowel disease. [4]
However, food tolerance varies between individuals.
Some people find that certain foods worsen diarrhea, bloating, or abdominal discomfort, particularly during a flare.
Others can eat a wide variety of foods without noticing specific triggers.
Practical topics to discuss with a healthcare professional or registered dietitian include:
- Maintaining adequate nutrition during periods of poor appetite.
- Identifying foods that seem to worsen digestive symptoms.
- Staying hydrated, especially when experiencing diarrhea.
- Avoiding unnecessary restrictive diets that may increase the risk of nutrient deficiencies.
- Choosing a balanced eating pattern that accommodates individual tolerances.
Diet was also a recurring topic in mama health's patient conversations, reflecting how important food choices can feel in everyday life with UC.
However, these experiences do not establish that dietary changes are equivalent to anti-inflammatory medication.
Stress management, rest, and emotional support can also be valuable parts of living with a chronic condition, even though they do not replace treatment for active intestinal inflammation.
What side effects and practical challenges should you discuss before starting treatment?
Before starting ulcerative colitis medication, it can be useful to understand the expected benefits, possible side effects, and practical requirements.
Different medications have different safety considerations.
For example:
- Corticosteroids can cause mood changes, insomnia, and other complications, particularly with prolonged use.
- Biologics can increase susceptibility to certain infections and may cause infusion or injection reactions.
- JAK inhibitors require careful evaluation of infection, blood clot, cardiovascular, and other risks.
- Immunomodulators may require ongoing blood tests and additional safety precautions.
The potential benefits and risks depend on the specific medication and individual medical history. [1, 2]
Practical factors matter too.
Some mama health patients described treatment interruptions related to insurance denials, high costs, and prior authorization requirements.
These concerns can be especially relevant in the United States, where coverage may differ substantially between health plans.
Questions worth discussing early include whether a prescribed medication requires prior authorization, how long an approval might take, and whether financial assistance programs or specialist pharmacy support are available.
Understanding these details may help make a treatment plan more manageable.
What questions should you ask your gastroenterologist about treatment?
Useful questions focus on why a treatment is being considered, what results to expect, what risks are involved, and what alternatives exist.
Based on concerns described in mama health patient conversations, the following questions can help prepare for an appointment.
Understanding your treatment
- Why are you recommending this medication for my ulcerative colitis?
- What are the potential benefits and risks compared with other options?
- Is this medication intended to bring my disease into remission, maintain remission, or both?
- How does my disease severity influence the treatment choice?
Understanding treatment response
- How long might it take before we can assess whether the treatment is working?
- How will we assess inflammation beyond how I feel?
- What happens if symptoms return while I'm tapering corticosteroids?
- What other options could we discuss if the medication stops working?
Understanding daily life and access
- How might this treatment affect my work, travel, or daily routine?
- What should we discuss if I experience joint pain, eye inflammation, mouth sores, or other symptoms outside the gut?
- Will my insurance require prior authorization, and what financial support might be available?
- What is the maintenance plan if I reach remission?
You do not need to ask every question in one appointment.
Choosing the topics that matter most to you can make the conversation more focused.
When should someone with ulcerative colitis seek urgent medical attention?
Severe or rapidly worsening symptoms can require urgent medical assessment.
Possible warning signs include substantial or persistent rectal bleeding, severe abdominal pain, a swollen or tender abdomen, high fever, fainting, or signs of significant dehydration.
Acute severe ulcerative colitis may require hospitalization and specialized treatment. [1, 3]
People experiencing these symptoms should seek prompt medical attention rather than waiting for a routine appointment.
Can ulcerative colitis be managed successfully over the long term?
Many people with ulcerative colitis can achieve prolonged periods of remission with appropriate medical care, although the disease course varies.
Long-term ulcerative colitis management may include maintenance medication, follow-up appointments, assessment of inflammation, nutritional support, and screening for complications when appropriate.
Some people remain well on the same medication for years. Others experience changes in disease activity and need different treatments over time.
A useful perspective from mama health's patient conversations is that treatment is a journey, not a single decision.
What matters is understanding your options, staying involved in discussions about your care, and having a plan with your gastroenterologist when circumstances change.
There may not be one universally best ulcerative colitis treatment, but there are multiple evidence-based options to discuss.
And you deserve to understand the reasoning behind the choices being considered for you.
Disclaimer: This content is informational and not a medical device. mama health offers information and support and does not replace a doctor.
This content is informational and is not medical advice.
mama health offers information and support and does not replace your doctor.
- American College of Gastroenterology (2025). Updated ACG Clinical Guidelines for Ulcerative Colitis in Adults. https://gi.org/journals-publications/ebgi/alkazzi_aug2025/
- Singh S, et al. (2024). AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis. Gastroenterology. https://gastro.org/clinical-guidance/living-guideline-for-moderate-to-severe-ulcerative-colitis/
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Treatment for Ulcerative Colitis. https://www.niddk.nih.gov/health-information/digestive-diseases/ulcerative-colitis/treatment
- American Gastroenterological Association (2024). Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Clinical Practice Update. https://gastro.org/clinical-guidance/diet-and-nutritional-therapies-in-patients-with-ibd/
- mama health patient conversations (United States): qualitative, paraphrased and anonymized insights. These accounts illustrate individual experiences and are not representative of everyone living with ulcerative colitis.
